格隆汇2月24日丨敷尔佳(301371.SZ)公布，近日，公司在研产品"重组Ⅲ型人源化胶原蛋白冻干纤维"已 完成临床试验并取得临床试验总结报告，可以进行注册申报材料递交。"重组Ⅲ型人源化胶原蛋白冻干 纤维"为公司首款浅层注射填充类产品，本次该产品完成临床试验并取得临床试验总结报告，标志着公 司已经可以进行注册申报材料递交，对公司开拓医美院线市场、丰富产品线具有重要意义。 ...

每经AI快讯，2月24日，敷尔佳(301371.SZ)公告称，公司在研产品"重组Ⅲ型人源化胶原蛋白冻干纤 维"已完成临床试验并取得总结报告，可进行注册申报材料递交。该产品为公司首款浅层注射填充类产 品，对开拓医美院线市场、丰富产品线具有重要意义。但医疗器械产品上市存在不确定性，短期内对公 司业绩不会造成重大影响。 （文章来源：每日经济新闻） ...

证券代码：301371 证券简称：敷尔佳 公告编号：2026-002 哈尔滨敷尔佳科技股份有限公司 关于第三类医疗器械产品完成临床试验的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 哈尔滨敷尔佳科技股份有限公司（以下简称"公司"）于 2024 年 9 月 26 日 披露了《关于第三类医疗器械产品完成临床试验备案的公告》（公告编号： 2024-056），公司在研产品"重组Ⅲ型人源化胶原蛋白冻干纤维"通过中国医学 科学院整形外科医院临床试验伦理委员会的伦理审查，并在黑龙江省药品监督管 理局完成医疗器械临床试验备案，已可以开展临床试验。 近日，公司在研产品"重组Ⅲ型人源化胶原蛋白冻干纤维"已完成临床试验 并取得临床试验总结报告，可以进行注册申报材料递交。具体情况公告如下： 一、基本情况 2、申办者地址：哈尔滨市松北区美谷路 500 号 3、试验名称：评价重组Ⅲ型人源化胶原蛋白冻干纤维用于改善面部皮肤状 态的有效性与安全性的前瞻性、多中心、随机、无治疗对照、评估者设盲、优效 性临床试验 4、试验目的：评价公司研制的重组Ⅲ型人源化胶原蛋白冻干纤维用于改善 面部皮 ...

Group 1 - The core point of the article is that the company Fuhua Jia (301371) reported a total of 16,620 shareholders as of February 10, 2026 [1]

Group 1 - The company, Fulejia (301371.SZ), stated that its directors and senior management currently have no intention to reduce their holdings [1]

Group 1 - The company, Fuhua, plans to register 48 cosmetic products by 2025, covering various forms such as water, lotion, cream, and essence [2][5] - Detailed product registration information can be found on the National Medical Products Administration website [2][5]

Core Viewpoint - The company, Fuhua, announced that it has completed the registration of two new raw materials, "Feruloyl Tripeptide-129 Amide" and "Acetyl Tyrosyl Cyclo D-Glutamyl Tripeptide-110 Amide," which are expected to enhance its product matrix by enabling further product development [1] Group 1 - The company plans to develop products based on the newly registered raw materials [1] - The registration of the new raw materials is expected to be completed by 2025 [1] - Detailed information regarding the raw material registration can be found on the National Medical Products Administration website [1]

Core Viewpoint - The company, Fuhua, is enhancing its research and development capabilities through a dual-center approach in Shanghai and Harbin, focusing on raw material development and medical device product research respectively [1] Group 1: Research and Development Strategy - The Shanghai R&D center is dedicated to raw material development and the application of cutting-edge technologies [1] - The Harbin R&D center specializes in the development of medical device products [1] - The company employs a coordinated internal and external research model, collaborating with third-party research institutions to expand diverse research directions [1] Group 2: Innovation and Competitiveness - The collaborative research focuses on efficacy validation and the application of new raw materials [1] - This internal-external synergy aims to enhance the R&D framework, balancing the autonomy and agility of technological innovation [1] - The strategy is designed to support product iteration and build long-term technological competitiveness [1]

Core Viewpoint - The company has received approval for four Class II medical device registration certificates, indicating progress in its product development and regulatory compliance [1] Group 1 - The company has obtained approval for four medical device registration certificates [1] - The approved products include: medical sodium hyaluronate repair patch, medical sodium hyaluronate repair solution, medical recombinant type III humanized collagen patch, and medical trehalose repair patch [1]

Core Viewpoint - Fuhua Jia (301371) is a specialized skin care product company focused on the research, production, and sales of professional skin care products, which are divided into medical device products and functional skin care products [1] Group 1: Product Offerings - The company's product forms include masks, waters, serums, lotions, sprays, freeze-dried products, and single-use serums [1] Group 2: Sales Strategy - The company employs an omnichannel strategy for sales, integrating both online and offline channels [1] - Online channels include major e-commerce and social media platforms such as Tmall, Douyin, JD.com, and Pinduoduo [1] - Offline channels penetrate cosmetic specialty stores, large supermarkets, chain pharmacies, beauty institutions, and medical institutions, creating a comprehensive market reach network [1]